Back to top
more

Quanterix (QTRX)

(Real Time Quote from BATS)

$17.72 USD

17.72
76,621

-0.16 (-0.90%)

Updated May 16, 2024 11:54 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (143 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

ResMed (RMD) Gains From Mask Sales Amid Macro Headwinds

ResMed's (RMD) respiratory care business continues to drive growth, courtesy of the adoption of bilevel and other non-invasive ventilator solutions worldwide.

Boston Scientific (BSX) Set to Acquire Relievant Medsystems

Boston Scientific's (BSX) new M&A deal is likely to broaden the Neuromodulation business portfolio.

Align (ALGN) Gains From Growing Invisalign Volume, Innovation

Align Technology (ALGN) is expanding its sales and marketing by reaching new countries and regions, including new areas within Africa and Latin America.

Medtronic (MDT) Gets CE Mark Approval for the New Simplera CGM

Medtronic's (MDT) next-generation sensor Simplera receives CE Mark approval.

Here's Why Investors Should Buy Alcon (ALC) Stock Right Now

Investors continue to be optimistic about Alcon (ALC) on the impressive performance of its portfolio.

Abbott (ABT) to Commercialize Biosimilars in Emerging Markets

Abbott (ABT) is set to commercialize several biosimilar molecules in key emerging markets via an expanded collaboration with mAbxience.

Orthofix (OFIX) Unveils Gemini System, Advances in Trauma Wing

According to Orthofix (OFIX), with the launch of the Galaxy Fixation Gemini system surgeons now have efficient solutions for lower extremity trauma scenarios where time is an important factor.

Hologic (HOLX) Gains From New Launches as Macro Concerns Rise

Hologic (HOLX) has been making impressive progress in its Breast Health arm, leveraging its strategic expansion efforts to diversify business across the patient continuum of care.

Abbott (ABT) Broadens Electrophysiology Footprint With TactiFlex

The successful deployment of Abbott's (ABT) TactiFlex Ablation Catheter, Sensor Enabled in Canada broadens the company's global footprint in the electrophysiology space.

Myriad Genetics (MYGN) Secures Key Milestones in Illumina Tie-Up

Myriad Genetics (MYGN) achieves significant milestones in its partnership with Illumina.

Phibro (PAHC) Sales Impacted by Macro Concerns, FX Headwind

The COVID-19 pandemic has adversely affected the international economic conditions and financial markets, leading to an economic downturn in many countries, in which Phibro (PAHC) operates.

Myriad Genetics' (MYGN) New Deal to Use MRD Testing Platform

Myriad Genetics (MYGN) announces a collaboration with Memorial Sloan Kettering Cancer Center to study the use of MRD testing in breast cancer.

Here's Why You Should Retain National Vision (EYE) Stock Now

Investors are optimistic about National Vision's (EYE) stock, banking on comparable store sales growth and stable liquidity.

Teleflex (TFX) Rides on Urolift Prospects Amid Cost Pressures

With respect to Teleflex's (TFX) market development objectives for UroLift, the company witnesses growth for UroLift in the hospital setting.

Teleflex (TFX) Picked for Vizient Innovative Technology Exchange

Teleflex (TFX) gets selected to exhibit Arrow VPS Rhythm DLX Device and Arrow PICCs preloaded with the NaviCurve Stylet at the Vizient Innovative Technology Exchange.

Alcon (ALC) Gains From Innovation & International Expansion

Alcon's (ALC) Surgical business continues to gain from diverse portfolio and incremental innovation.

Teleflex (TFX) New Survey Highlights BPH Impact Life Quality

Teleflex's (TFX) survey results highlight how crucial it is for men to consult a urologist if they have strange or troublesome urine symptoms.

Charles River (CRL) Announces Partnership With Related Sciences

Charles River's (CRL) new collaboration is likely to leverage the AI-powered drug discovery and development platform, Logica.

Here's Why You Should Retain Insulet (PODD) Stock for Now

Investors continue to be optimistic about Insulet (PODD) on the strength of the Omnipod 5 AID system.

Quest Diagnostics (DGX) to Aid Health Equity With New Pact

Quest Diagnostics (DGX) and Americares will provide 10 clinics with no-cost diagnostic services for a year to help patients manage chronic disease.

Here's Why You Should Retain SmileDirectClub (SDC) Stock for Now

Investors are optimistic about SmileDirectClub (SDC) on the latest technology enhancements and upbeat guidance.

Chemed (CHE) Faces Macroeconomic Woes, Tough Competition

Inflationary trend, increased logistics costs and higher employee-related expenses continue to hurt Chemed's (CHE) growth.

Vicarious Surgical (RBOT) to Broaden User Network With New Deal

Vicarious Surgical's (RBOT) partnership with Intermountain Health is likely to help the company gain access to Intermountain Health's extensive network.

CVS Health's (CVS) New COVID-19 Vaccine Available at Its Stores

CVS Health's (CVS) updated mRNA COVID-19 vaccine is now available at all its pharmacy locations.

Walgreens (WBA) Expands Primary Care Research With New Pact

Walgreens (WBA) will reach more communities quickly and provide comprehensive, cost-effective care with the new collaboration.